Background: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort. Methods: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF. Results: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria. Conclusion: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.

Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort / Gensluckner, Sophie; Wernly, Bernhard; Koutny, Florian; Strebinger, Georg; Zandanell, Stephan; Stechemesser, Lars; Paulweber, Bernhard; Iglseder, Bernhard; Trinka, Eugen; Frey, Vanessa; Langthaler, Patrick; Semmler, Georg; Valenti, Luca; Corradini, Elena; Datz, Christian; Aigner, Elmar. - In: BIOMEDICINES. - ISSN 2227-9059. - 12:1(2024), pp. 1-13. [10.3390/biomedicines12010207]

Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

Corradini, Elena;
2024

Abstract

Background: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort. Methods: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF. Results: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria. Conclusion: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.
2024
17-gen-2024
12
1
1
13
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort / Gensluckner, Sophie; Wernly, Bernhard; Koutny, Florian; Strebinger, Georg; Zandanell, Stephan; Stechemesser, Lars; Paulweber, Bernhard; Iglseder, Bernhard; Trinka, Eugen; Frey, Vanessa; Langthaler, Patrick; Semmler, Georg; Valenti, Luca; Corradini, Elena; Datz, Christian; Aigner, Elmar. - In: BIOMEDICINES. - ISSN 2227-9059. - 12:1(2024), pp. 1-13. [10.3390/biomedicines12010207]
Gensluckner, Sophie; Wernly, Bernhard; Koutny, Florian; Strebinger, Georg; Zandanell, Stephan; Stechemesser, Lars; Paulweber, Bernhard; Iglseder, Bernhard; Trinka, Eugen; Frey, Vanessa; Langthaler, Patrick; Semmler, Georg; Valenti, Luca; Corradini, Elena; Datz, Christian; Aigner, Elmar
File in questo prodotto:
File Dimensione Formato  
biomedicines-12-00207.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 449.06 kB
Formato Adobe PDF
449.06 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1335849
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact